Abstract

Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (aka "pseudocellulitis") and treated with antibiotics and/or hospitalization. There is limited data on the cost and complications from misdiagnosed cellulitis. To characterize the national health care burden of misdiagnosed cellulitis in patients admitted for treatment of lower extremity cellulitis. Cross-sectional study using patients admitted from the emergency department (ED) of a large urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012. Patients who were discharged with a diagnosis of cellulitis were categorized as having cellulitis, while those who were given an alternative diagnosis during the hospital course, on discharge, or within 30 days of discharge were considered to have pseudocellulitis. A literature review was conducted for calculation of large-scale costs and complication rates. We obtained national cost figures from the Medical Expenditure Panel Survey (MEPS), provided by the Agency for Healthcare Research and Quality (AHRQ) for 2010 to calculate the hospitalization costs per year attributed to misdiagnosed lower extremity pseudocellulitis. The exposed group was composed of patients who presented to and were admitted from the ED with a diagnosis of lower extremity cellulitis. Patient characteristics, hospital course, and complications during and after hospitalization were reviewed for each patient, and estimates of annual costs of misdiagnosed cellulitis in the United States. Of 259 patients, 79 (30.5%) were misdiagnosed with cellulitis, and 52 of these misdiagnosed patients were admitted primarily for the treatment of cellulitis. Forty-four of the 52 (84.6%) did not require hospitalization based on ultimate diagnosis, and 48 (92.3%) received unnecessary antibiotics. We estimate cellulitis misdiagnosis leads to 50 000 to 130 000 unnecessary hospitalizations and $195 million to $515 million in avoidable health care spending. Unnecessary antibiotics and hospitalization for misdiagnosed cellulitis are projected to cause more than 9000 nosocomial infections, 1000 to 5000 Clostridium difficile infections, and 2 to 6 cases of anaphylaxis annually. Misdiagnosis of lower extremity cellulitis is common and may lead to unnecessary patient morbidity and considerable health care spending.

Highlights

  • Unnecessary antibiotics and hospitalization for misdiagnosed cellulitis are projected to cause more than 9000 nosocomial infections, 1000 to 5000 Clostridium difficile infections, and 2 to 6 cases of anaphylaxis annually

  • Cellulitis is a common bacterial skin infection that leads to 2.3 million emergency department (ED) visits annually in the United States.[1]

  • Cellulitis ambulatory care costs in the United States in 2006 were $3.7 billion,[5] a cost that continues to rise as ambulatory visits and inpatient admissions increase.[6,7]

Read more

Summary

Methods

Case Identification and Data Collection We performed a retrospective cross-sectional study of all patients presenting to and admitted from the ED of a large urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012. Information stored in the RPDR includes patient demographics, medications, laboratory reports, and visit notes. We queried the RPDR using ICD9 codes for lower extremity cellulitis (681.10, 682.6, 682.7, 682.8, 682.9), location of service (ED), and age (≥18 years) to identify eligible patients. Patients 18 years or older who were diagnosed with cellulitis by the ED physician or admitting team, presented directly to the ED, and were subsequently admitted were eligible for inclusion in the study. Exclusion criteria included non–lower extremity cellulitis, intravenous antibiotics within the 48 hours prior to presentation, surgery within the prior 30 days, abscess, penetrating trauma, burn, known osteomyelitis, diabetic ulcer, or indwelling hardware at site.

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call